These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18020969)

  • 1. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial.
    Herrmann M; Umanskaya N; Traber L; Schmidt-Gayk H; Menke W; Lanzer G; Lenhart M; Peter Schmidt J; Herrmann W
    Clin Chem Lab Med; 2007; 45(12):1785-92. PubMed ID: 18020969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate supplementation does not affect biochemical markers of bone turnover.
    Herrmann M; Stanger O; Paulweber B; Hufnagl C; Herrmann W
    Clin Lab; 2006; 52(3-4):131-6. PubMed ID: 16584059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Vitamin B12 and Folic Acid Supplementation on Bone Mineral Density and Quantitative Ultrasound Parameters in Older People with an Elevated Plasma Homocysteine Level: B-PROOF, a Randomized Controlled Trial.
    Enneman AW; Swart KM; van Wijngaarden JP; van Dijk SC; Ham AC; Brouwer-Brolsma EM; van der Zwaluw NL; Dhonukshe-Rutten RA; van der Cammen TJ; de Groot LC; van Meurs J; Lips P; Uitterlinden AG; Zillikens MC; van Schoor NM; van der Velde N
    Calcif Tissue Int; 2015 May; 96(5):401-9. PubMed ID: 25712255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid and vitamin B(12) supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial.
    Keser I; Ilich JZ; Vrkić N; Giljević Z; Colić Barić I
    Nutr Res; 2013 Mar; 33(3):211-9. PubMed ID: 23507227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PINP as an aid for monitoring patients treated with teriparatide.
    Tsujimoto M; Chen P; Miyauchi A; Sowa H; Krege JH
    Bone; 2011 Apr; 48(4):798-803. PubMed ID: 21168536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women.
    Haliloglu B; Aksungar FB; Ilter E; Peker H; Akin FT; Mutlu N; Ozekici U
    Arch Gynecol Obstet; 2010 Apr; 281(4):663-8. PubMed ID: 19946695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.
    Rogers A; Glover SJ; Eastell R
    Bone; 2009 Dec; 45(6):1044-52. PubMed ID: 19665601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
    Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
    J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.
    Matsumoto T; Miki T; Hagino H; Sugimoto T; Okamoto S; Hirota T; Tanigawara Y; Hayashi Y; Fukunaga M; Shiraki M; Nakamura T
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5031-6. PubMed ID: 15972580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans.
    Morris MS; Jacques PF; Selhub J
    Bone; 2005 Aug; 37(2):234-42. PubMed ID: 15950558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homocysteine, B vitamins and bone mineral density in osteoporosis: a possible risk for bone fracture.
    Ebesunun MO; Umahoin KO; Alonge TO; Adebusoye LA
    Afr J Med Med Sci; 2014 Mar; 43(1):41-7. PubMed ID: 25335377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women.
    Herrmann M; Kraenzlin M; Pape G; Sand-Hill M; Herrmann W
    Clin Chem Lab Med; 2005; 43(10):1118-23. PubMed ID: 16197308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year B and D vitamins supplementation improves metabolic bone markers.
    Herrmann W; Kirsch SH; Kruse V; Eckert R; Gräber S; Geisel J; Obeid R
    Clin Chem Lab Med; 2013 Mar; 51(3):639-47. PubMed ID: 23183751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.
    Recker RR; Benson CT; Matsumoto T; Bolognese MA; Robins DA; Alam J; Chiang AY; Hu L; Krege JH; Sowa H; Mitlak BH; Myers SL
    J Bone Miner Res; 2015 Feb; 30(2):216-24. PubMed ID: 25196993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people.
    Dhonukshe-Rutten RA; Pluijm SM; de Groot LC; Lips P; Smit JH; van Staveren WA
    J Bone Miner Res; 2005 Jun; 20(6):921-9. PubMed ID: 15883631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
    Wolters M; Hermann S; Hahn A
    Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.